Misti Paudel

Assistant Professor

Harvard University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Misti Paudel is an Assistant Professor at Harvard University, specializing in rheumatology and interstitial lung diseases associated with rheumatoid arthritis. Her recent research includes developing predictive models for disease progression and investigating the risks of serious infections and mortality in rheumatoid arthritis patients. Dr. Paudel's work is critical in understanding the complexities of treatment challenges in rheumatic diseases.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Collaborators (3)

Min Uk Kim

Seoul Metropolitan Government Seoul National University Boramae Medical Center

SOUTH KOREA

View details

Chanho Park

SOUTH KOREA

View details

Jeffrey Sparks

Associate Physician/Associate Professor of Medicine

Brigham and Women's Hospital

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Misti Paudel

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Risk of serious infection in patients with rheumatoid arthritis‐associated interstitial lung disease or bronchiectasis: A comparative cohort study

Risk of total and cause-specific mortality in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis

Serum Biomarkers of Pulmonary Damage and Risk for Progression of Rheumatoid Arthritis–Associated Interstitial Lung Disease

Development and External Validation of a Multivariable Predictive Model for Progression to Difficult‐to‐Treat Rheumatoid Arthritis in Biologic‐Experienced Patients

Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors: The prospective KORAIL cohort

Prevalence and characteristics of adults with difficult-to-treat rheumatoid arthritis in a large patient registry

The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms

Impact of Sex, Serostatus, and Smoking on Risk for Rheumatoid Arthritis–Associated Interstitial Lung Disease Subtypes

Longitudinal analysis of serum urate in prediabetic phase

Gout risk in adults with pre-diabetes initiating metformin

Collaborators (3)

Min Uk Kim

Chanho Park

Jeffrey Sparks

Make your next move.